HUNTINGTON BANCSHARES INC /MD/ (HBAN) reported revenue of $472.00M and net income of $523.00M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HUNTINGTON BANCSHARES INC /MD/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under National Commercial Banks.
Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $472.00M | $410.00M | $424.00M | $377.00M | $351.00M | $410.00M | $362.00M | $360.00M | $336.00M | $353.00M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | $523.00M | $519.00M | $629.00M | $536.00M | $527.00M | $530.00M | $517.00M | $474.00M | $419.00M | $243.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 1.90B | Unavailable | shares 1.48B | shares 1.48B | shares 1.48B | Unavailable | shares 1.48B | shares 1.47B | shares 1.47B | Unavailable |
| Pretax income | $641.00M | $631.00M | $766.00M | $638.00M | $653.00M | $669.00M | $638.00M | $586.00M | $510.00M | $247.00M |
| Income tax expense | $114.00M | $108.00M | $133.00M | $96.00M | $122.00M | $135.00M | $116.00M | $106.00M | $86.00M | -$1.00M |
| Diluted EPS | $0.25 | Unavailable | $0.41 | $0.34 | $0.34 | Unavailable | $0.33 | $0.30 | $0.26 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $285.37B | $225.11B | $210.23B | $207.74B | $209.60B | $204.23B | $200.54B | $196.31B | $193.52B | $189.37B |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $252.79B | $200.73B | $187.94B | $186.77B | $189.11B | $184.45B | $179.88B | $176.75B | $174.15B | $169.97B |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $32.58B | $24.38B | $22.29B | $20.97B | $20.49B | $19.78B | $20.65B | $19.56B | $19.37B | $19.40B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $9.53B | $6.00B | $5.55B | $5.56B | $5.56B | $5.56B | $5.56B | $5.56B | $5.56B | $5.56B |
| Long-term debt | $21.59B | $17.22B | $17.32B | $17.47B | $18.10B | $16.37B | $15.66B | $16.46B | $14.89B | $12.39B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $524.00M | $928.00M | $487.00M | $554.00M | $513.00M | $1.12B | -$58.00M | $297.00M | $482.00M | $898.00M |
| Capital expenditures | $124.00M | $118.00M | $41.00M | $54.00M | $54.00M | $27.00M | $42.00M | $42.00M | $32.00M | $60.00M |
| Investing cash flow | -$135.00M | -$1.44B | -$266.00M | -$2.50B | -$2.15B | -$4.78B | -$2.88B | -$2.19B | -$2.26B | -$3.31B |
| Financing cash flow | $5.30B | $1.26B | $2.16B | -$3.01B | $4.10B | $3.93B | $2.98B | $2.26B | $3.83B | $1.10B |
| Net change in cash | $5.69B | $757.00M | $2.38B | -$4.95B | $2.46B | $262.00M | $39.00M | $366.00M | $2.05B | -$1.31B |
| Stock-based compensation | $45.00M | $29.00M | $31.00M | $32.00M | $21.00M | $25.00M | $28.00M | $33.00M | $20.00M | $24.00M |
| Common dividends paid | $248.00M | $228.00M | $227.00M | $227.00M | $226.00M | $226.00M | $226.00M | $225.00M | $226.00M | $226.00M |
| Common share repurchases | $150.00M | Unavailable | Unavailable | Unavailable | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $191.00M | $190.00M | $175.00M | $188.00M | $209.00M | $130.00M | $132.00M | $170.00M | $190.00M | $240.00M |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $400.00M | $810.00M | $446.00M | $500.00M | $459.00M | $1.09B | -$100.00M | $255.00M | $450.00M | $838.00M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | 84.7% | 197.6% | 105.2% | 132.6% | 130.8% | 265.4% | -27.6% | 70.8% | 133.9% | 237.4% |
| SBC / revenue | 9.5% | 7.1% | 7.3% | 8.5% | 6.0% | 6.1% | 7.7% | 9.2% | 6.0% | 6.8% |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 34.5% | 0.0% | 17.1% | 4.7% | 4.5% | 16.1% | 7.1% | 8.4% | -10.9% | 2.9% |
| Net margin | 110.8% | 126.6% | 148.3% | 142.2% | 150.1% | 129.3% | 142.8% | 131.7% | 124.7% | 68.8% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 26.3% | 28.8% | 9.7% | 14.3% | 15.4% | 6.6% | 11.6% | 11.7% | 9.5% | 17.0% |
| Long-term debt / equity | 0.66x | 0.71x | 0.78x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 17.8% | 17.1% | 17.4% | 15.0% | 18.7% | 20.2% | 18.2% | 18.1% | 16.9% | -0.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HBAN in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.